Skip to content

Tomosynthesis in Screening Mammography

A Study to Determine Patient Benefit of Tomosynthesis in Screening Mammography

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01086241
Enrollment
500
Registered
2010-03-15
Start date
2010-05-31
Completion date
2014-04-30
Last updated
2025-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Density

Keywords

Tomography, Mammography, Breast Neoplasms, Prevention and Control

Brief summary

Tomosynthesis is a new digital mammographic tool which can be performed at the same time as routine screening mammography. It creates CT-like slices through the breast, minimizing the tissue overlap. Tomosynthesis has the potential to improve screening mammography outcomes by increasing cancer detection rates, decreasing false negative rates and false positive rates. This trial will help determine if tomosynthesis is useful in a screening setting.

Detailed description

We will evaluate the effect of tomosynthesis mammography outcomes in a screening setting. We will collect data on interpretation time, recall rates, cancer detection rates, and interval cancer rates in dense breasts(≥ 50% glandular density). If the interpretation time is less than 4X a routine read, and the recall rates have dropped \< 30% of initial values, we will then conduct a study with larger numbers to better evaluate cancer detection rates and interval cancer rates.

Interventions

PROCEDURE2D Mammogram

Those patients randomized to the mammogram arm will receive a regular 2D mammogram. Compression lasts several seconds in order to obtain 4 views. The x-ray tube is programmed to obtain an arc of low dose projection images through the breast.

PROCEDURETomosynthesis

Those patients randomized to the tomosynthesis arm will receive a combination of 3D and 2D screening mammogram. The additional tomosynthesis data is obtained immediately after acquisition of the 2D study, with the patient and breast remaining in the same position and compression. Compression lasts about 7 seconds longer for each of the 4 views. The x-ray tube is programmed to obtain an arc of low dose projection images through the breast.

Sponsors

Hologic, Inc.
CollaboratorINDUSTRY
AHS Cancer Control Alberta
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* Females 40-69 years of age attending Screen Test Kingsway referred for a screening mammogram as defined by Canadian Cancer Society guidelines. * Prior mammogram report indicating ≥ 25% breast density.

Exclusion criteria

* Prior mammogram report indicating \<25% breast density. * Breast implants * Pregnancy

Design outcomes

Primary

MeasureTime frame
Interpretation Time of ScanWithin 1 month of receiving scan

Secondary

MeasureTime frame
Recall Rates6 month intervals for 2 years after initial scan
Discomfort ScaleImmediately after the subject receives scan

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026